Frank Rigo

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods for reducing Ataxin-2 expression
- Patent number 12,188,020
- Issue date Jan 7, 2025
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for detection of SMN protein in a subject...
- Patent number 12,013,403
- Issue date Jun 18, 2024
- Biogen MA Inc.
- Frank Rigo
- G01 - MEASURING TESTING
Information Patent Grant
Compounds and methods for reducing ATXN2 expression
- Patent number 11,926,825
- Issue date Mar 12, 2024
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligomeric compounds for reducing DMPK expression
- Patent number 11,833,221
- Issue date Dec 5, 2023
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and methods for modulating GFAP
- Patent number 11,786,546
- Issue date Oct 17, 2023
- Ionis Pharmaceuticals, Inc.
- Berit Elissa Powers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating Alzheimer's disease
- Patent number 11,781,135
- Issue date Oct 10, 2023
- Washington University
- Timothy M. Miller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds and methods for the modulation of amyloid-β precursor pro...
- Patent number 11,732,260
- Issue date Aug 22, 2023
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Conjugated antisense compounds and their use
- Patent number 11,725,208
- Issue date Aug 15, 2023
- Ionis Pharmaceuticals, Inc.
- Michael Oestergaard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for modulating FMR1 expression
- Patent number 11,661,601
- Issue date May 30, 2023
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for modulation of SMN2 splicing in a subject
- Patent number 11,535,848
- Issue date Dec 27, 2022
- Biogen MA Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulation of frataxin expression
- Patent number 11,459,564
- Issue date Oct 4, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions for modulating C9ORF72 expression
- Patent number 11,339,393
- Issue date May 24, 2022
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- G01 - MEASURING TESTING
Information Patent Grant
Compounds and methods for modulating SMN2
- Patent number 11,299,737
- Issue date Apr 12, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for modulating Ataxin 3 expression
- Patent number 11,293,025
- Issue date Apr 5, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds and methods for modulating C90RF72
- Patent number 11,260,073
- Issue date Mar 1, 2022
- Ionis Pharmaceuticals, Inc.
- Thazha P. Prakash
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense compounds and uses thereof
- Patent number 11,236,330
- Issue date Feb 1, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combinations for the modulation of SMN expression
- Patent number 11,198,867
- Issue date Dec 14, 2021
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions for modulating expression of C9ORF72 antisense transcript
- Patent number 11,193,128
- Issue date Dec 7, 2021
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for modulating expression of C9ORF72 antisense transcript
- Patent number 11,162,096
- Issue date Nov 2, 2021
- Ionis Pharmaceuticals, Inc.
- C. Frank Bennett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for modulating Tau expression
- Patent number 11,155,815
- Issue date Oct 26, 2021
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for modulation of IKBKAP splicing
- Patent number 11,066,668
- Issue date Jul 20, 2021
- Ionis Pharmaceuticals, Inc.
- C. Frank Bennett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating breast cancer
- Patent number 11,058,709
- Issue date Jul 13, 2021
- Ionis Pharmaceuticals, Inc.
- David L. Spector
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulation of Lnc05 expression
- Patent number 11,033,570
- Issue date Jun 15, 2021
- Cold Spring Harbor Laboratory
- Allen Tingjin Yu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modulation of SMN expression
- Patent number 10,851,371
- Issue date Dec 1, 2020
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions for modulating C9ORF72 expression
- Patent number 10,815,483
- Issue date Oct 27, 2020
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions for modulating expression of C9ORF72 antisense transcript
- Patent number 10,793,855
- Issue date Oct 6, 2020
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for modulation nucleic acids through nonse...
- Patent number 10,590,412
- Issue date Mar 17, 2020
- Ionis Pharmaceuticals, Inc.
- Amanda Ward
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compounds and methods for modulation of DUX4
- Patent number 10,538,763
- Issue date Jan 21, 2020
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for modulating Ataxin 3 expression
- Patent number 10,533,175
- Issue date Jan 14, 2020
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense compounds targeting apolipoprotein E receptor 2
- Patent number 10,472,634
- Issue date Nov 12, 2019
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Compounds and Methods for Reducing ATXN2 Expression
- Publication number 20240401039
- Publication date Dec 5, 2024
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION
- Publication number 20240360449
- Publication date Oct 31, 2024
- Ionis Pharmaceuticals, Inc.
- Paymaan Jafar-nejad
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION
- Publication number 20240336915
- Publication date Oct 10, 2024
- Ionis Pharmaceuticals, Inc.
- Ruben E. Valas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds and Methods for Reducing DMPK Expression
- Publication number 20240335556
- Publication date Oct 10, 2024
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds and Methods for Modulating GFAP
- Publication number 20240285669
- Publication date Aug 29, 2024
- Ionis Pharmaceuticals, Inc.
- Berit Elissa Powers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Methods for Modulating Splicing of Pre-MRNA
- Publication number 20240287513
- Publication date Aug 29, 2024
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
- Publication number 20240279664
- Publication date Aug 22, 2024
- Ionis Pharmaceuticals, Inc.
- Michael Oestergaard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT
- Publication number 20240238326
- Publication date Jul 18, 2024
- Biogen MA Inc.
- C. Frank Bennett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions for Modulating C9ORF72 Expression
- Publication number 20240200067
- Publication date Jun 20, 2024
- Ionis Pharmaceuticals, Inc.
- C. Frank Bennett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR MODULATING FMR1 EXPRESSION
- Publication number 20240175021
- Publication date May 30, 2024
- Ionis Pharmaceuticals, Inc.
- Frank RIGO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING SCN2A
- Publication number 20240102012
- Publication date Mar 28, 2024
- Ionis Pharmaceuticals, Inc.
- Paymaan Jafar-Nejad
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING SCN2A
- Publication number 20240026353
- Publication date Jan 25, 2024
- Ionis Pharmaceuticals, Inc.
- Paymaan Jafar-Nejad
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF
- Publication number 20230338555
- Publication date Oct 26, 2023
- Ionis Pharmaceuticals, Inc.
- Thazha P. Prakash
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS
- Publication number 20230201374
- Publication date Jun 29, 2023
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Modulation of SMN2 Splicing in a Subject
- Publication number 20230183696
- Publication date Jun 15, 2023
- Biogen MA Inc.
- Frank RIGO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING SPLICING OF PRE-MRNA
- Publication number 20230117089
- Publication date Apr 20, 2023
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR REDUCING DMPK EXPRESSION
- Publication number 20230114429
- Publication date Apr 13, 2023
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions for Modulating C9ORF72 Expression
- Publication number 20230112920
- Publication date Apr 13, 2023
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION
- Publication number 20230043648
- Publication date Feb 9, 2023
- Ionis Pharmaceuticals, Inc.
- Paymaan Jafar-Nejad
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION
- Publication number 20230040829
- Publication date Feb 9, 2023
- Ionis Pharmaceuticals, Inc.
- Frank RIGO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING C90RF72
- Publication number 20230020192
- Publication date Jan 19, 2023
- Ionis Pharmaceuticals, Inc.
- Thazha P. PRAKASH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds and Methods for Modulating UBE3A-ATS
- Publication number 20220411793
- Publication date Dec 29, 2022
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE COMPOUNDS AND USES THEREOF
- Publication number 20220372473
- Publication date Nov 24, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING CLN3 EXPRESSION
- Publication number 20220280545
- Publication date Sep 8, 2022
- Ionis Pharmaceuticals, Inc.
- Michelle L. Hastings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION
- Publication number 20220243200
- Publication date Aug 4, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR REDUCING ATAXIN-2 EXPRESSION
- Publication number 20220162615
- Publication date May 26, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING BREAST CANCER
- Publication number 20220143066
- Publication date May 12, 2022
- Cold Spring Harbor Laboratory
- David L. Spector
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compounds and Methods for Use in Dystrophin Transcript
- Publication number 20220081689
- Publication date Mar 17, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATION OF SMN2
- Publication number 20220073914
- Publication date Mar 10, 2022
- Ionis Pharmaceuticals, Inc.
- Frank Rigo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Methods for Reducing ATXN2 Expression
- Publication number 20220064639
- Publication date Mar 3, 2022
- Ionis Pharmaceuticals, Inc.
- Susan M. Freier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Methods for reducing Ataxin-2 expression

Compositions and methods for detection of SMN protein in a subject...

Compounds and methods for reducing ATXN2 expression

Oligomeric compounds for reducing DMPK expression

Compounds and methods for modulating GFAP

Methods for treating Alzheimer's disease

Compounds and methods for the modulation of amyloid-β precursor pro...

Conjugated antisense compounds and their use

Methods for modulating FMR1 expression

Compositions and methods for modulation of SMN2 splicing in a subject

Modulation of frataxin expression

Compositions for modulating C9ORF72 expression

Compounds and methods for modulating SMN2

Compositions and methods for modulating Ataxin 3 expression

Compounds and methods for modulating C90RF72

Antisense compounds and uses thereof

Combinations for the modulation of SMN expression

Compositions for modulating expression of C9ORF72 antisense transcript

Methods for modulating expression of C9ORF72 antisense transcript

Compositions and methods for modulating Tau expression

Compositions and methods for modulation of IKBKAP splicing

Methods of treating breast cancer

Modulation of Lnc05 expression

Modulation of SMN expression

Compositions for modulating C9ORF72 expression

Compositions for modulating expression of C9ORF72 antisense transcript

Compositions and methods for modulation nucleic acids through nonse...

Compounds and methods for modulation of DUX4

Compositions and methods for modulating Ataxin 3 expression

Antisense compounds targeting apolipoprotein E receptor 2

Patents Applicationslast 30 patents

Compounds and Methods for Reducing ATXN2 Expression

COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION

COMPOUNDS AND METHODS FOR REDUCING DUX4 EXPRESSION

Compounds and Methods for Reducing DMPK Expression

Compounds and Methods for Modulating GFAP

Compounds and Methods for Modulating Splicing of Pre-MRNA

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT

Compositions for Modulating C9ORF72 Expression

METHODS FOR MODULATING FMR1 EXPRESSION

COMPOUNDS AND METHODS FOR MODULATING SCN2A

COMPOUNDS AND METHODS FOR MODULATING SCN2A

CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS

Compositions and Methods for Modulation of SMN2 Splicing in a Subject

COMPOUNDS AND METHODS FOR MODULATING SPLICING OF PRE-MRNA

COMPOUNDS AND METHODS FOR REDUCING DMPK EXPRESSION

Compositions for Modulating C9ORF72 Expression

COMPOUNDS AND METHODS FOR MODULATING SCN1A EXPRESSION

COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION

COMPOUNDS AND METHODS FOR MODULATING C90RF72

Compounds and Methods for Modulating UBE3A-ATS

ANTISENSE COMPOUNDS AND USES THEREOF

COMPOUNDS AND METHODS FOR MODULATING CLN3 EXPRESSION

COMPOSITIONS AND METHODS FOR MODULATING TAU EXPRESSION

METHODS FOR REDUCING ATAXIN-2 EXPRESSION

METHODS OF TREATING BREAST CANCER

Compounds and Methods for Use in Dystrophin Transcript

COMPOUNDS AND METHODS FOR MODULATION OF SMN2

Compounds and Methods for Reducing ATXN2 Expression